Cargando…

OR03-2 Phase 1, Randomized, Controlled Trial of GFB-024, a Once-Monthly CB1 Inverse Agonist, in Healthy Overweight and Obese Participants and in Participants with Type 2 Diabetes Mellitus

Evidence from nonclinical studies suggests a role of cannabinoid-1 receptor (CB1) in the development of diabetic nephropathy (DN). Kidney CB1 expression is upregulated in podocytes and tubular cells in murine models of obesity and diabetes mellitus (DM). Inhibition by CB1 inverse agonists has been s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bilic, Sanela, Dagon, Yossi, Gustafson, Thomas, Johnson, Leslie, Lawler, John, Rudolph-Own, Lori, Gaich, Gregory, Tucker, Edwin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Diabetes & Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624947/ http://dx.doi.org/10.1210/jendso/bvac150.723

Ejemplares similares

P03-024 – Early onset IBD treated by tocilizumab
por: Helbling, R, et al.
Publicado: (2013)

MON-LB024 Episodic Hypoglycemia in Non-Diabetics: Differentiating Distressing from Deadly
por: Windham, Mary, et al.
Publicado: (2019)

SAT-LB024 Imprecision in Biomarker Analysis: Major Hurdle to Detection and Reversal of Disorders of Aging?
por: Comite, Florence, et al.
Publicado: (2019)

PW03-024 - A transgenic mouse model for variant procaspase-1
por: Hermsdorf, A, et al.
Publicado: (2013)

SUN-LB024 Elevation in Morning Glucose Level May Be a Signal for the Development of Immune Checkpoint Inhibitor (ICPi) Induced Autoimmune Diabetes Insulin
por: Zhang, Amy, et al.
Publicado: (2019)

Determination of Volatile Organic Compounds and Antibacterial Activity of the Amazonian Cyanobacterium Synechococcus sp. Strain GFB01
por: do Amaral, Samuel Cavalcante, et al.
Publicado: (2020)

Safety and Efficacy of GFB-887, a TRPC5 Channel Inhibitor, in Patients With Focal Segmental Glomerulosclerosis, Treatment-Resistant Minimal Change Disease, or Diabetic Nephropathy: TRACTION-2 Trial Design
por: Walsh, Liron, et al.
Publicado: (2021)

OR03-3 Impact of Continuous Glucose Monitoring (CGM) on Lifestyle Modifications in Individuals with Prediabetes
por: Khan, Shanzay, et al.
Publicado: (2022)

Association between electronic nicotine delivery systems use and risk of stroke: a meta-analysis of 1,024,401 participants
por: Awad, Kamal, et al.
Publicado: (2023)

FRI622 Impact Of Personalized Diet Using Digital Twin On Body Composition Parameters: 180 Day Analysis Of 209 Participants
por: Shamanna, Paramesh, et al.
Publicado: (2023)

Preclinical Characterization of Once Weekly Basal Insulin Fc (BIF)
por: Moyers, Julie S, et al.
Publicado: (2021)

SAT-LB029 Patient Participation Is Determined by Referral Source in an Intensive Diabetes Management Program
por: Blase, Bryan, et al.
Publicado: (2019)

OR03-4 Efficacy and Safety of Avexitide for Treatment of Hypoglycemia after Gastrointestinal Surgery; Assessment of Novel Dosing Regimens in an Expanded Indication
por: Craig, Colleen, et al.
Publicado: (2022)

Draft Genome Sequence of the Picocyanobacterium Synechococcus sp. Strain GFB01, Isolated from a Freshwater Lagoon in the Brazilian Amazon
por: Guimarães, Pedro Ivo, et al.
Publicado: (2015)

Glucosidase Inhibitors Screening in Microalgae and Cyanobacteria Isolated from the Amazon and Proteomic Analysis of Inhibitor Producing Synechococcus sp. GFB01
por: Gradíssimo, Diana Gomes, et al.
Publicado: (2021)

OR12-03 The Pancreatic Islet Alpha Cell Arginine Transporter SLC7A2 Regulates Arginine-induced Glucagon Secretion and Glycemia
por: Stanley, Jade E, et al.
Publicado: (2023)

MON-172 Morbid Thoughts Improve in Participants with Uncontrolled Diabetes after a Mental Health Educational Program
por: Emerson, Jonathan, et al.
Publicado: (2019)

SUN-LB116 Improved Family Medicine Resident Diabetes Care Through Participation in a Diabetes Clinic
por: Douthitt, Key, et al.
Publicado: (2020)

OR03-5 Identification of Four New Glucotypes during the First Year after Type 1 Diabetes Onset Using Continuous Glucose Monitoring Metrics
por: Delfosse, Antoine, et al.
Publicado: (2022)

OR18-03 Peripheral But Not Hepatic Insulin Resistance Associates With Adverse Vascular And Metabolic Health In Type 1 Diabetes: A Possible Target For Adjunctive Therapy
por: Snaith, Jennifer R, et al.
Publicado: (2023)

SUN-LB122 Sequential Testing to Assess Insulin Resistance in the Course of Participation in a Diabetes Prevention Program (DPP)
por: McPhaul, Michael John, et al.
Publicado: (2020)

OR34-03 Defining Clinical Characteristics Of Patients With Severe Hypoglycemia After Roux-en-Y Gastric Bypass: How Do They Differ From Asymptomatic Patients?
por: Grover, Ashna, et al.
Publicado: (2023)

Comparison of Once-Daily Bromfenac 0.07% Versus Once-Daily Nepafenac 0.3% in Patients Undergoing Phacoemulsification
por: Toyos, Melissa M.
Publicado: (2019)

OR26-03 Lower Serum Myostatin Levels Are Associated with Higher Insulin Sensitivity in Adults with Overweight/Obesity
por: Haines, Melanie S, et al.
Publicado: (2020)

FRI612 Tirzepatide For The Treatment Of Post-bariatric Surgery Hypoglycemia And Early Dumping Syndrome
por: Frederick Stortz, Ethan, et al.
Publicado: (2023)

OR30-03 Racial Differences in Technology Use Among Type 1 Diabetes in a Safety-Net Hospital
por: Wirunsawanya, Kamonkiat, et al.
Publicado: (2020)

OR14-03 The Transcriptional Coactivation Function of EHMT2 Restricts Chronic Glucocorticoid Exposure Induced Insulin Resistance
por: Lee, Rebecca Arwyn, et al.
Publicado: (2020)

OR08-03 Association of Hemoglobin A1c with Early Postpartum Metabolic Syndrome in Women with Gestational Diabetes
por: Blair, Rachel A, et al.
Publicado: (2020)

SUN-665 Peripheral CB(1)R Blocker Improves Metabolism in Diet Induced Obese Mice Independent of Hepatic FGF21
por: Liu, Jie, et al.
Publicado: (2020)

Letrozole in the neoadjuvant setting: the P024 trial
por: Ellis, Matthew J., et al.
Publicado: (2007)

Letrozole in the neoadjuvant setting the P024 trial
por: Ellis, Matthew J., et al.
Publicado: (2007)

OR03-1 Achievement of HbA1c <6.5% without weight gain and hypoglycemia in people with type 2 diabetes treated with tirzepatide across the phase 3 SURPASS program
por: Allen, Sheryl Elaine, et al.
Publicado: (2022)

P03-14 Barriers to sports participation among adolescent girls from deprived neighbourhoods
por: Ljungmann, Cecilie Karen, et al.
Publicado: (2022)

OR03-6 Further Clinical Evaluation of Stem Cell-Derived Islet Replacement Therapy (VC-02) Demonstrates Production of C-Peptide with Improvements in Glycemic Control Parameters in Multiple Patients with Type 1 Diabetes and Hypoglycemia Unawareness
por: Bellin, Melena, et al.
Publicado: (2022)

Long-Term Effectiveness and Safety of Once Weekly Dulaglutide as Add-on to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes
por: Mirabelli, Maria, et al.
Publicado: (2021)

CMS ARDA Meeting, ARDA-Note-2004-024
por: CERN. Geneva
Publicado: (2004)

Lysophosphatidylinositol Promotes Chemotaxis and Cytokine Synthesis in Mast Cells with Differential Participation of GPR55 and CB2 Receptors
por: Martínez-Aguilar, Lizbeth Magnolia, et al.
Publicado: (2023)

Once Weekly Basal Insulin Fc (BIF) is Safe and Efficacious in Patients with Type 2 Diabetes Mellitus (T2DM) Previously Treated With Basal Insulin
por: Frias, Juan Pablo, et al.
Publicado: (2021)

SAT-133 Vida Sana Year 3: Improvements in Health Literacy and Risk Factors for Metabolic Syndrome in Participants in a Healthy Lifestyle Initiative at a Clinic for Low-Income Inner City Patients
por: Villasante Fricke, Alexandra, et al.
Publicado: (2019)

Insertion Sequence (IS) Element-Mediated Activating Mutations of the Cryptic Aromatic β-Glucoside Utilization (BglGFB) Operon Are Promoted by the Anti-Terminator Protein (BglG) in Escherichia coli
por: Zhang, Zhongge, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_17llko68lp56gk8m7o71aq0848